PHVS

Pharvaris N.V.$35.15+0.75 (+2.18%)

Prev Close$34.42·MCap$2.45B·P/E—·Vol126.9K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$12.09M

◆

Net Activity

Net Seller

$12.09M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Pharvaris N.V. (PHVS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 26 insider sales totaling $12.09M. The most recent insider transaction was by Modig Berndt (director, officer: Chief Executive Officer), who sold $80.2K worth of shares on Jul 15, 2026. Pharvaris N.V. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.45B.

PHVS Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 15, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	2,292	$34.97	$80.2K	132,917
Jul 1, 2026	Lesage Anne	officer: Chief Early Development	Sell	76,172	$35.39	$2.70M	124,672-38%
Jul 1, 2026	Schikan Johannes Gerardus Christiaan Petrus	director	Sell	37,600	$35.41	$1.33M	345,879
Jun 29, 2026	Lu Peng	officer: Chief Medical Officer	Sell	29,700	$34.30	$1.02M	69,031-30%
Jun 29, 2026	Schikan Johannes Gerardus Christiaan Petrus	director	Sell	2,400	$35.10	$84.2K	352,767
Jun 29, 2026	Lesage Anne	officer: Chief Early Development	Sell	2,300	$35.12	$80.8K	131,669
Jun 23, 2026	Lu Peng	officer: Chief Medical Officer	Sell	300	$34.00	$10.2K	65,631
Jun 17, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	2,291	$31.07	$71.2K	135,309
Jun 8, 2026	Nijdam Anna	officer: Principal Accounting Officer	Sell	2,670	$30.87	$82.4K	46,275
May 26, 2026	Monges Viviane	director	Sell	9,667	$30.29	$292.9K	5,500-64%
May 26, 2026	Nassif David W.	officer: CFO / CLO	Sell	10,000	$30.31	$303.1K	120,300
May 26, 2026	Nijdam Anna	officer: Principal Accounting Officer	Sell	7,330	$30.70	$225.1K	48,945
May 22, 2026	Bjork Elisabeth	director	Sell	10,000	$29.32	$293.2K	15,167-40%
May 20, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	2,292	$29.22	$67.0K	137,500
May 19, 2026	Souverijns Wim	officer: Chief Commercial Officer	Sell	10,000	$29.92	$299.2K	45,111
May 19, 2026	Glassman Robert	director	Sell	10,000	$29.82	$298.2K	15,167-40%
May 19, 2026	Abele Stefan Andreas	officer: Chief Technical Ops Officer	Sell	8,748	$29.82	$260.9K	35,194
May 5, 2026	Lu Peng	officer: Chief Medical Officer	Sell	14,166	$30.17	$427.4K	66,226
May 1, 2026	Lu Peng	officer: Chief Medical Officer	Sell	18,733	$30.21	$565.9K	66,083
May 1, 2026	Lesage Anne	officer: Chief Early Development	Sell	40,900	$30.24	$1.24M	153,169
May 1, 2026	Schikan Johannes Gerardus Christiaan Petrus	director	Sell	32,900	$30.29	$996.5K	384,237
Apr 24, 2026	Lesage Anne	officer: Chief Early Development	Sell	7,600	$30.05	$228.4K	156,969
Apr 24, 2026	Lu Peng	officer: Chief Medical Officer	Sell	7,101	$30.05	$213.4K	66,083
Apr 24, 2026	Schikan Johannes Gerardus Christiaan Petrus	director	Sell	7,100	$30.05	$213.4K	388,167
Apr 20, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	2,292	$28.60	$65.6K	139,792
Apr 10, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	23,333	$27.74	$647.3K	142,284

PHVS Insider Buying Activity

The following table shows recent insider purchases of Pharvaris N.V. (PHVS) stock reported via SEC Form 4 filings.

No insider buying activity found for PHVS in the last 12 months.

PHVS Insider Selling Activity

The following table shows recent insider sales of Pharvaris N.V. (PHVS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jul 15, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	2,292	$34.97	$80.2K	132,917
Jul 1, 2026	Lesage Anne	officer: Chief Early Development	Sell	76,172	$35.39	$2.70M	124,672-38%
Jul 1, 2026	Schikan Johannes Gerardus Christiaan Petrus	director	Sell	37,600	$35.41	$1.33M	345,879
Jun 29, 2026	Lu Peng	officer: Chief Medical Officer	Sell	29,700	$34.30	$1.02M	69,031-30%
Jun 29, 2026	Schikan Johannes Gerardus Christiaan Petrus	director	Sell	2,400	$35.10	$84.2K	352,767
Jun 29, 2026	Lesage Anne	officer: Chief Early Development	Sell	2,300	$35.12	$80.8K	131,669
Jun 23, 2026	Lu Peng	officer: Chief Medical Officer	Sell	300	$34.00	$10.2K	65,631
Jun 17, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	2,291	$31.07	$71.2K	135,309
Jun 8, 2026	Nijdam Anna	officer: Principal Accounting Officer	Sell	2,670	$30.87	$82.4K	46,275
May 26, 2026	Monges Viviane	director	Sell	9,667	$30.29	$292.9K	5,500-64%
May 26, 2026	Nassif David W.	officer: CFO / CLO	Sell	10,000	$30.31	$303.1K	120,300
May 26, 2026	Nijdam Anna	officer: Principal Accounting Officer	Sell	7,330	$30.70	$225.1K	48,945
May 22, 2026	Bjork Elisabeth	director	Sell	10,000	$29.32	$293.2K	15,167-40%
May 20, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	2,292	$29.22	$67.0K	137,500
May 19, 2026	Souverijns Wim	officer: Chief Commercial Officer	Sell	10,000	$29.92	$299.2K	45,111
May 19, 2026	Glassman Robert	director	Sell	10,000	$29.82	$298.2K	15,167-40%
May 19, 2026	Abele Stefan Andreas	officer: Chief Technical Ops Officer	Sell	8,748	$29.82	$260.9K	35,194
May 5, 2026	Lu Peng	officer: Chief Medical Officer	Sell	14,166	$30.17	$427.4K	66,226
May 1, 2026	Lu Peng	officer: Chief Medical Officer	Sell	18,733	$30.21	$565.9K	66,083
May 1, 2026	Lesage Anne	officer: Chief Early Development	Sell	40,900	$30.24	$1.24M	153,169
May 1, 2026	Schikan Johannes Gerardus Christiaan Petrus	director	Sell	32,900	$30.29	$996.5K	384,237
Apr 24, 2026	Lesage Anne	officer: Chief Early Development	Sell	7,600	$30.05	$228.4K	156,969
Apr 24, 2026	Lu Peng	officer: Chief Medical Officer	Sell	7,101	$30.05	$213.4K	66,083
Apr 24, 2026	Schikan Johannes Gerardus Christiaan Petrus	director	Sell	7,100	$30.05	$213.4K	388,167
Apr 20, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	2,292	$28.60	$65.6K	139,792
Apr 10, 2026	Modig Berndt	director, officer: Chief Executive Officer	Sell	23,333	$27.74	$647.3K	142,284